N Østerås1, A T Tveter2, A M Garratt3, O E Svinøy4, I Kjeken5, B Natvig6, M Grotle7, K B Hagen8. 1. National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, N-0319, Oslo, Norway. Electronic address: nina.osteras@medisin.uio.no. 2. National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, N-0319, Oslo, Norway. Electronic address: a.t.tveter@medisin.uio.no. 3. Division of Health Services, Norwegian Institute for Public Health, PO Box 4404 Nydalen, N-0403 Oslo, Norway. Electronic address: andrew.garratt@fhi.no. 4. Faculty of Health Sciences, OsloMet-Oslo Metropolitan University, PO Box 4 St. Olavs plass, N-0130 Oslo, Norway. Electronic address: oddeina@oslomet.com. 5. National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, N-0319, Oslo, Norway. Electronic address: ingvild.kjeken@diakonsyk.no. 6. Department of General Practice, Institute of Health and Society, University of Oslo, PO Box 1130 Blindern, N-0318 Oslo, Norway. Electronic address: bard.natvig@medisin.uio.no. 7. Faculty of Health Sciences, OsloMet-Oslo Metropolitan University, PO Box 4 St. Olavs plass, N-0130 Oslo, Norway. Electronic address: margreth.grotle@oslomet.no. 8. National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, N-0319, Oslo, Norway. Electronic address: kare.birger.hagen@fhi.no.
Abstract
OBJECTIVES: To assess validity, reliability, responsiveness and interpretability of the revised OsteoArthritis Quality Indicator (OA-QI) questionnaire version 2 (v2) assessing patient-reported quality of osteoarthritis care. METHODS: The OA-QI v2 (16 items, score range 0-100 (100 = best score)) was included in a longitudinal cohort study. Attendees of a 4.5 h osteoarthritis patient education programme at Diakonhjemmet Hospital, Norway, completed the OA-QI at four time points: 2 weeks before, immediately before, immediately after, and 3 months after the programme. Test-retest reliability and measurement error over a 2-week time period were assessed in those that had not seen health professionals in the interim. Construct validity and responsiveness were assessed with predefined hypotheses. Floor and ceiling effects, smallest detectable change (SDC95%) and minimal important change (MIC) were assessed to evaluate interpretability. RESULTS: The intraclass correlation coefficient for all 16 items was 0.89. For single items the test-retest kappa estimates ranged 0.38-0.85 and percent agreement 69-92%. Construct validity was acceptable with all six predefined hypotheses confirmed. Responsiveness was acceptable with 33 of 48 and three of four predefined hypotheses confirmed for single items and all items, respectively. There were no floor or ceiling effects. The SDC95% was 29.1 and 3.0 at the individual and group levels, respectively. MIC was 20.4. CONCLUSIONS: The OA-QI v2 had higher reliability estimates compared to v1, showed acceptable validity, and is the recommended version for future use. The results of responsiveness testing further support the use of the OA-QI v2 as an outcome measure in studies aiming to improve osteoarthritis care.
OBJECTIVES: To assess validity, reliability, responsiveness and interpretability of the revised OsteoArthritis Quality Indicator (OA-QI) questionnaire version 2 (v2) assessing patient-reported quality of osteoarthritis care. METHODS: The OA-QI v2 (16 items, score range 0-100 (100 = best score)) was included in a longitudinal cohort study. Attendees of a 4.5 h osteoarthritispatient education programme at Diakonhjemmet Hospital, Norway, completed the OA-QI at four time points: 2 weeks before, immediately before, immediately after, and 3 months after the programme. Test-retest reliability and measurement error over a 2-week time period were assessed in those that had not seen health professionals in the interim. Construct validity and responsiveness were assessed with predefined hypotheses. Floor and ceiling effects, smallest detectable change (SDC95%) and minimal important change (MIC) were assessed to evaluate interpretability. RESULTS: The intraclass correlation coefficient for all 16 items was 0.89. For single items the test-retest kappa estimates ranged 0.38-0.85 and percent agreement 69-92%. Construct validity was acceptable with all six predefined hypotheses confirmed. Responsiveness was acceptable with 33 of 48 and three of four predefined hypotheses confirmed for single items and all items, respectively. There were no floor or ceiling effects. The SDC95% was 29.1 and 3.0 at the individual and group levels, respectively. MIC was 20.4. CONCLUSIONS: The OA-QI v2 had higher reliability estimates compared to v1, showed acceptable validity, and is the recommended version for future use. The results of responsiveness testing further support the use of the OA-QI v2 as an outcome measure in studies aiming to improve osteoarthritis care.
Authors: Ilgin G Arslan; Rianne M Rozendaal; Marienke van Middelkoop; Saskia A G Stitzinger; Maarten-Paul Van de Kerkhove; Vincent M I Voorbrood; Patrick J E Bindels; Sita M A Bierma-Zeinstra; Dieuwke Schiphof Journal: RMD Open Date: 2021-05
Authors: Simon Majormoen Bruhn; Lina Holm Ingelsrud; Thomas Bandholm; Søren Thorgaard Skou; Henrik M Schroder; Susanne Reventlow; Anne Møller; Jakob Kjellberg; Thomas Kallemose; Anders Troelsen Journal: BMJ Open Date: 2021-07-07 Impact factor: 2.692